DossierENTITY

Koselugo

Coverage of Koselugo in the Nexus archive.

Earliest in view: Jul 15 · 19:34 UTCMost recent: Jul 15 · 19:34 UTC

Co-mentioned in this coverage

Recent coverage

HEALTHJul 15 · 19:34 UTCMEDPAGE TODAY
Restarting Selumetinib Promising for Recurrent Low-Grade Glioma in Kids
Retreatment with the MEK inhibitor selumetinib (Koselugo) shows promise for children with recurrent low-grade glioma, according to prospective evidence presented at the International Symposium on Pediatric Neuro-Oncology (ISPNO).